Avricore Health (TSX-V:AVCR, OTC:AVCRF) passed a significant milestone in its commercial journey as it reported its first-ever profit in the three months ended March 31, posting $168,537 of comprehensive income. Revenue for the period increased by 79% year over year to $1.12 million, while gross profit rose by 130% to $484,791.
| Professional Services Industry | Industrials Sector | Mr. Hector Bremner CEO | OTC PINK Exchange | 054521109 CUSIP |
| CA Country | - Employees | - Last Dividend | 21 Nov 2016 Last Split | - IPO Date |
Avricore Health Inc. is a pioneering company in the health data and point-of-care technologies sector, based in Vancouver, Canada. Initially founded in 1996, the company embarked on its journey under the name Vanc Pharmaceuticals Inc. In October 2018, it underwent a significant rebranding, changing its name to Avricore Health Inc., marking a new era in its commitment to revolutionizing the way healthcare is delivered and managed. Avricore Health Inc. specializes in transforming pharmacies into community point-of-care diagnostic centers, making healthcare more accessible and efficient for the public.